Training activity information
Details
Review the dose constraints for a clinical site. Make recommendations considering safety, efficacy, outcomes and the suitability and impact on the patient
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Origin of dose constraints
- New evidence and relevant studies
- Patient safety and outcomes
- Patient toxicity/side effects
- Individualised treatment planning, including patient tolerance and suitability for treatment
- Patient centred care and support
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are typical dose constraints for this clinical site and why are they in place?
- What are the critical organs at risk?
- What is the evidence base for these constraints?
- What factors relate to safety, efficacy, outcomes, and patient suitability?
- Have you discussed the current constraints with relevant clinicians and physicists?
- How will you balance different considerations when making recommendations?
- How do you feel about making recommendations that could impact patient treatment?
In action
- What evidence base are you considering (e.g., published literature, clinical protocols)?
- How are you evaluating the balance between safety, efficacy, and potential patient outcomes?
- What patient-specific factors might influence the appropriateness of the dose constraints?
- Are you able to understand the rationale behind the current dose constraints?
- Are you identifying any potential areas where the constraints might be too restrictive or not sufficiently protective?
- Are you considering the potential impact of the dose constraints on treatment planning and delivery?
- If you are proposing changes to the dose constraints, what is your justification based on safety, efficacy, and patient impact?
- Are you considering alternative dose constraints or planning techniques that might improve the therapeutic ratio?
- Are you preparing to discuss your recommendations with the multidisciplinary team?
On action
- What were the current dose constraints for the clinical site? What evidence or guidelines were used to establish these constraints? What potential risks and benefits were associated with the current constraints? What patient factors and potential outcomes were considered in your review? What were the specific recommendations you made and the rationale behind them?
- What did you learn about your ability to critically evaluate dose constraints from a multidisciplinary perspective, considering radiobiological principles, clinical outcomes data, and the potential impact on the patient’s quality of life? Did you identify any areas where your knowledge of clinical radiobiology or treatment outcomes could be improved?
- How will this enhance your ability to critically review and evaluate dose constraints? How will this improve your skills in formulating and justifying recommendations for dose optimisation? What further knowledge of clinical radiobiology and treatment outcomes would be beneficial?
Beyond action
- Looking back at your recommendations, how would you evaluate them now based on your increased knowledge of dose constraints and clinical outcomes?
- Have you been involved in setting or reviewing dose constraints for other clinical sites since this activity? How did this experience inform your approach?
- How has your ability to critically appraise dose constraints since contributed to your current practice in optimising treatment plans for individual patients?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Perform dosimetric and radiobiological calculations. |
| # 4 |
Outcome
Critically appraise the application of radiotherapy treatments and techniques and make recommendations considering safety, efficacy, outcomes and the suitability and impact on the patient. |
| # 5 |
Outcome
Evaluate the application of novel and evolving techniques and treatments in radiotherapy. |
| # 7 |
Outcome
Assess the quality of practice and make recommendations for improvements. |